title: Detection of vancomycin heteroresistant Staphylococcus haemolyticus and vancomycin intermediate resistant Staphylococcus epidermidis by means of vancomycin screening agar.
authors.forename: Yoke-Fong
authors.initials: YF
authors.lastname: Chiew
authors.forename: Musuka
authors.initials: M
authors.lastname: Charles
authors.forename: Maree C
authors.initials: MC
authors.lastname: Johnstone
authors.forename: Kim M
authors.initials: KM
authors.lastname: Thompson
authors.forename: Kyle D
authors.initials: KD
authors.lastname: Parnell
authors.forename: Erin C
authors.initials: EC
authors.lastname: Penno
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000208:Acute Disease; D000328:Adult; D000362:Agar; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D004351:Drug Resistance; D006801:Humans; D016867:Immunocompromised Host; D007951:Leukemia, Myeloid / Q000628:therapy; D000069349:Linezolid; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods*; D023303:Oxazolidinones / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000276:immunology; D013212:Staphylococcus epidermidis / Q000187:drug effects; D041162:Staphylococcus haemolyticus / Q000187:drug effects; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000362:Agar; D000069349:Linezolid